The global cell surface markers market size was US$ 601 million in 2021. The global cell surface markers market size is forecast to reach US$ 1367 million by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2022 to 2030.

A cell surface marker is a special protein or a compound attached to a cell membrane that serves as a convenient characterizing characteristic. Lymphocytes differentiate into multiple subtypes of cells, necessary for specific biological processes. While some proteins allow molecules to cross the membrane, cell surface markers facilitate communication and recognition between cells. This helps classify cells according to their surface markers. This data, in turn, allows one to identify different cell types, from cancer cells to stem cells to cells infected with HIV. Essentially, cell surface markers are like fingerprints specific to the type of cell and are identifiable according to what kinds of markers are present on the membrane.

Factors Influencing Market Growth

• The increased funding for life sciences research, the high global incidence of cancer, and the growth of stem cell and neurobiology research are expected to drive the growth of this market over the next few years.
• Several factors are driving the growth of this market, including advancements in healthcare technology and a growing preference to reduce healthcare costs by lowering diagnosis costs. 
• Cell marker analysis requires complicated products and expensive instruments and reagents, which may slow down the market growth.

Impact Analysis of COVID-19

COVID-19 has had a significant impact on the market. A cell surface marker is a sugar or a protein attached to the cell membrane, allowing the cell surface marker to play a crucial role in intercellular communication. Several research projects investigate the interaction between COVID-19 antibodies and cell surface markers. As a result of their decreased immunity, COVID-19 patients are more likely to become infected with secondary fungi. Therefore, the use of cell surface markers to study fungal infection had boosted the growth of the global cell surface market. 

Regional Insights

North America is the largest regional market for cell surface markers. Cell surface markers have become an increasingly important part of personalized medicine and drug discovery & development, owing to the increasing number of R&D activities.

During the forecast period, Asia Pacific is forecast to grow at the highest CAGR. The high growth of the market in the Asia Pacific is due to an increase in the number of life sciences research activities and initiatives by governments to boost the biotechnology and pharmaceutical industries.

Leading Competitors

The leading prominent companies profiled in the global cell surface markers market are:

• Thermo Fisher Scientific
• QIAGEN N.V.
• Becton, Dickinson, and Company
• F. Hoffman-La Roche
• Bio-Rad Laboratories
• Danaher Corporation
• Abcam
• GenScript
• BioLegend
• Cell Signaling Technology
• Merck KGaA
• Bio-Techne
• Other Prominent Players

Scope of the Report

The global cell surface markers market segmentation focuses on Product, Source, Application, End-User, and Region.

Segmentation based on Product

• Antibody
• PCR Array

Segmentation based on End-User

• Research Institutes
• Pharmaceutical & Biotechnology Industry
• Others

Segmentation based on Application

• Research
• Clinical
• Others

Segmentation based on Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
• South America
  • Brazil
  • Argentina
  • Rest of South America

[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL CELL SURFACE MARKERS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL CELL SURFACE MARKERS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL CELL SURFACE MARKERS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ANTIBODY
5.3 PCR ARRAY

6 GLOBAL CELL SURFACE MARKERS MARKET, BY END-USER
6.1 OVERVIEW
6.2 RESEARCH INSTITUTES
6.3 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY
6.4 OTHERS

7 GLOBAL CELL SURFACE MARKERS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 RESEARCH
7.3 CLINICAL
7.4 OTHERS

8 GLOBAL CELL SURFACE MARKERS MARKET, BY GEOGRAPHY
8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO

8.3 EUROPE

8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE

8.4 ASIA PACIFIC

8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA

8.6 SOUTH AMERICA

8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA

9 GLOBAL CELL SURFACE MARKERS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

10.1 THERMO FISHER SCIENTIFIC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS

10.2 QIAGEN N.V.
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS

10.3 BECTON, DICKINSON, AND COMPANY
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS

10.4 F. HOFFMAN-LA ROCHE
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS

10.5 BIO-RAD LABORATORIES
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS

10.6 DANAHER CORPORATION
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS

10.7 ABCAM
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS

10.8. GENSCRIPT
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS

10.9 BIOLEGEND
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS

10.10 CELL SIGNALING TECHNOLOGY
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS

10.11 MERCK KGAA
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS

10.12 BIO-TECHNE
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS